Author Archive for: tanderson@mdic.org

Entries by

Developing the Roadmap for NESTcc Active Surveillance Activities

On January 30, 2019, NESTcc convened the first meeting of its Active Surveillance Task Force.  This multi-stakeholder group is tasked with developing a Roadmap for how to establish active surveillance capabilities and tools within the NESTcc Data Network.  Not all risks of a device nor their true frequency can be identified in premarket studies. After […]

NESTcc Establishes Active Surveillance Task Force

On December 13, 2018, the NESTcc Governing Committee approved the establishment of a small, multi-stakeholder Active Surveillance Task Force tasked with establishing a blueprint for leveraging NESTcc’s work to advance active surveillance and subsequently launch NESTcc’s first active surveillance projects.  The Task Force will develop a blueprint by Spring 2019, and the first active surveillance […]

A Look Ahead to What’s Next for NESTcc in 2019

Less than a month in, 2019 is shaping up to be another landmark year for the NESTcc.  In an effort to further advance our mission to accelerate the development and translation of new and safe health technologies, leveraging Real-World Evidence (RWE), and innovative research, NESTcc’s Governing Committee has approved our Strategic & Operational Plan for […]

2018│NESTcc’s Year in Review

As we wrap up NESTcc’s busiest year to date, I’d like to reflect on the landmark achievements and milestones that have been accomplished over the past twelve months, guided by NESTcc’s 2018 Strategic & Operational Plan. 2018 was marked by firsts for NESTcc, starting with our first Data Strategy Convening meeting in February where we […]

Developing the NESTcc Active Surveillance Portfolio

In 2016, the National Evaluation System for health Technology Coordinating Center (NESTcc) was established, in part, to help address the timely and robust identification of safety signals for medical devices.  NESTcc has received dedicated funding from the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) to advance active surveillance activities […]